Integrative Computational Analysis of TP53 Exon 5–6 Mutations in Oral Cavity, Prostate, and Breast Cancers in a Senegalese Population
Open Access
Abstract
Background/Objectives: The tumor suppressor gene TP53 is one of the most frequently mutated genes in human cancers, with alterations predominantly affecting its DNA-binding domain (DBD). However, the mutational landscape and functional consequences of TP53 variants remain poorly characterized in African populations. This study aimed to characterize mutations in exons 5–6 of TP53 in oral cavity cancer (OCC), prostate cancer (PC), and breast cancer (BC) in a Senegalese population, and to assess their structural effects, functional consequences, and impact on protein–protein interactions with BCL-2. Methods: Seventy-eight archived tumor DNA samples from Senegalese patients with OCC, PC, and BC were analyzed. Variants were annotated using COSMIC and dbSNP databases. Functional impact was evaluated with PolyPhen-2. Structural stability changes () were predicted using FoldX, conformational dynamics () were assessed with ENCoM, and effects on the p53–BCL-2 interaction were analyzed using DDMut-PPI. Statistical analyses were also performed. Results: BC exhibited the highest TP53 mutation frequency, whereas OCC showed greater mutational diversity. Exon-level analysis revealed a significant enrichment of exon 6 mutations in BC. Structural analyses indicated that exon 5 mutations across all cancers and mutations in OCC were predominantly destabilizing and associated with loss-of-function effects. In contrast, recurrent exon 6 mutations in PC and BC, particularly V217L and V218M, were predicted to stabilize the p53 structure. Conformational dynamics differences between exons were significant only in PC. All analyzed mutations were predicted to stabilize the p53–BCL-2 interaction. Conclusions: This integrative in silico study identified cancer and exon-specific TP53 mutation patterns in a Senegalese population, highlighting exon 6 as a context-dependent hotspot with potential oncogenic implication in PC and BC. Despite its computational nature, the study provides valuable insights that merit further investigation.
Keywords
All Related Versions
This publication has 32 references indexed in Scilit:
- Novel Mutations in Acute Erythroid Leukemia–A Case Report with Review of LiteratureIndian Journal of Hematology and Blood Transfusion, 2024
- BRCA1, BRCA2, TP53, PIK3CA, PTEN and AKT1 genes mutations in Burkina Faso breast cancer patients: prevalence, spectrum and novel variantMolecular Genetics and Genomics, 2022
- TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next DecadeHuman Mutation, 2014
- Recommendations for Analyzing and ReportingTP53Gene Variants in the High-Throughput Sequencing EraHuman Mutation, 2014
- High intratumor genetic heterogeneity is related to worse outcome in patients with head and neck squamous cell carcinomaCancer, 2013
- Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2Current Protocols in Human Genetics, 2013
- Analyse de l’état du stress oxydatif dans le cancer du sein à l’Ouest algérien via les tests FORD et FORT et corrélation avec le grade histopronostique SBRJournal africain du cancer / African Journal of Cancer, 2012
- Distinct tumor protein p53 mutants in breast cancer subgroupsInternational Journal of Cancer, 2012
- When mutants gain new powers: news from the mutant p53 fieldNature Reviews Cancer, 2009
- Reassessment of theTP53 mutation database in human disease by data mining with a library ofTP53 missense mutationsHuman Mutation, 2004